公司資料
Creative Medical Technology Holdings 股價、新聞與催化劑
- 股票代碼:
- CELZ
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.10 USD (-9.84%)
收盤價
最後更新: 2026年8月17日
8.24M USD
市值
股價為何變動
As of Aug 17, 2026, CELZ closed down 9.84% at $1.10. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Creative Medical Technology Holdings is a regenerative medicine company focused on cell-based and biologic approaches to difficult diseases. Its story is built around early-stage platform science and the possibility of translating regenerative concepts into practical therapies.
所在地與產業分類
Creative Medical Technology is headquartered in the United States and listed on NASDAQ. It sits in regenerative medicine and small-cap biotech rather than commercial pharma.
商業模式特徵
The company depends on preclinical and early clinical validation, platform credibility, and capital support. Investors typically watch scientific updates, financing, and whether the company can narrow its story into a viable development path.
生技產業定位
Creative Medical Technology occupies a speculative regenerative-medicine niche within biotech. It tends to trade on platform promise more than on near-term commercial visibility.
未來催化劑
- Creative Medical’s catalysts are regenerative-medicine and immunotherapy programs, plus any update that shows the company can still create a path forward. The stock remains very much proof-of-concept driven.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。